Skip to main content
. Author manuscript; available in PMC: 2014 Dec 1.
Published in final edited form as: Infect Dis Clin North Am. 2013 Oct 31;27(4):10.1016/j.idc.2013.08.001. doi: 10.1016/j.idc.2013.08.001

Figure 1.

Figure 1

Proportion of Gonococcal Isolates Tested by GISP with CDC ‘Alert Value’ MIC§ to Cefixime*, Ceftriaxone, Azithromycin and with Resistance† to Doxycycline and Ciprofloxacin: 2006 - August 2011.

§CDC defines alert value MIC to Cefixime as ≥0.25 μg/mL, Ceftriaxone ≥0.125 μg/mL, and Azithromycin ≥2.0 μg/mL. †CDC defines doxycycline resistance as MIC ≥2.0 μg/mL and ciprofloxacin resistance as ≥1.0 μg/mL. *Cefixime MIC were not tested in 2007 and 2008. Data compiled from CDC STD Surveillance Reports 2006 – 2011.